Matches in SemOpenAlex for { <https://semopenalex.org/work/W3031567761> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3031567761 endingPage "619" @default.
- W3031567761 startingPage "617" @default.
- W3031567761 abstract "Objective To evaluate the clinical toxicity and efficacy of S-1 combined with γ-ray body stereotactic radiation therapy in treatment of locally advanced pancreatic cancer.Methods Forty-five patients with locally advanced pancreatic cancer were randomly divided into two groups.The combination group received γ-ray stereotactic body radiation therapy which was given isodose curve of 50 ％-60 ％,tumor encircling dose of 3.0-4.5 Gy per fraction depended on dimension of tumors,9-12 fractions.Combined with S-1 40 mg/m2,2 times/d,for consecutive twenty-one days for four courses.The control group was given γ-ray stereotactic body radiation therapy only.Toxicities and effects were evaluated according to the criteria of WHO and RTOG.Results The CR rates in combination group and control group were 30.4 ％ (7/23) and 13.6 ％ (3/22),the response rates were 91.3 ％ (21/23) and 63.6 ％ (14/22) (x2 =4.980,P =0.026).The rates of gastrointestinal tract side reaction in combination group and control group were 82.6 ％ and 68.2 ％ (x2 =1.267,P =0.260),myelosuppression in combination group and control group were 78.3 ％ and 63.6 ％ (x2 =1.171,P =0.279).The rate of Ⅲ-Ⅳ grade myelosuppression in combination group were higher than that in control group (x2 =4.874,P =0.027).The median progression-free survival (PFS) rates of two groups were 8 months and 6 months respectively (x2 =1.357,P ＞ 0.05),the median survival period were 17 months and 14 months (x2 =1.017,P ＞ 0.05),1 year survival rates were 60.9 ％ and 54.5 ％ respectively (x2 =0.184,P ＞ 0.05).Conclusions S-1 combined with body gamma system treatment can improve local control rate and effective rate for inoperable patients with local advanced pancreatic carcinoma,and the adverse reactions are well tolerated.This method can be used as locally advanced pancreatic cancer chemoradiation safe and effective choice.Key words: Pancreatic neoplasms; S-1; γ-ray stereotactic body radiation therapy; Therapy" @default.
- W3031567761 created "2020-06-05" @default.
- W3031567761 creator A5008408386 @default.
- W3031567761 creator A5050334711 @default.
- W3031567761 creator A5054633518 @default.
- W3031567761 creator A5056759536 @default.
- W3031567761 creator A5083115574 @default.
- W3031567761 date "2014-09-28" @default.
- W3031567761 modified "2023-10-11" @default.
- W3031567761 title "Clinical observation of S-1 combined with γ-ray stereotactic body radiation therapy in treatment of locally advanced pancreatic cancer" @default.
- W3031567761 doi "https://doi.org/10.3760/cma.j.issn.1006-9801.2014.09.010" @default.
- W3031567761 hasPublicationYear "2014" @default.
- W3031567761 type Work @default.
- W3031567761 sameAs 3031567761 @default.
- W3031567761 citedByCount "0" @default.
- W3031567761 crossrefType "journal-article" @default.
- W3031567761 hasAuthorship W3031567761A5008408386 @default.
- W3031567761 hasAuthorship W3031567761A5050334711 @default.
- W3031567761 hasAuthorship W3031567761A5054633518 @default.
- W3031567761 hasAuthorship W3031567761A5056759536 @default.
- W3031567761 hasAuthorship W3031567761A5083115574 @default.
- W3031567761 hasConcept C121608353 @default.
- W3031567761 hasConcept C126322002 @default.
- W3031567761 hasConcept C141071460 @default.
- W3031567761 hasConcept C2776999253 @default.
- W3031567761 hasConcept C2780210213 @default.
- W3031567761 hasConcept C2989005 @default.
- W3031567761 hasConcept C509974204 @default.
- W3031567761 hasConcept C71924100 @default.
- W3031567761 hasConcept C90924648 @default.
- W3031567761 hasConceptScore W3031567761C121608353 @default.
- W3031567761 hasConceptScore W3031567761C126322002 @default.
- W3031567761 hasConceptScore W3031567761C141071460 @default.
- W3031567761 hasConceptScore W3031567761C2776999253 @default.
- W3031567761 hasConceptScore W3031567761C2780210213 @default.
- W3031567761 hasConceptScore W3031567761C2989005 @default.
- W3031567761 hasConceptScore W3031567761C509974204 @default.
- W3031567761 hasConceptScore W3031567761C71924100 @default.
- W3031567761 hasConceptScore W3031567761C90924648 @default.
- W3031567761 hasIssue "09" @default.
- W3031567761 hasLocation W30315677611 @default.
- W3031567761 hasOpenAccess W3031567761 @default.
- W3031567761 hasPrimaryLocation W30315677611 @default.
- W3031567761 hasRelatedWork W1490687610 @default.
- W3031567761 hasRelatedWork W2148609561 @default.
- W3031567761 hasRelatedWork W2355352881 @default.
- W3031567761 hasRelatedWork W2363441136 @default.
- W3031567761 hasRelatedWork W2364460732 @default.
- W3031567761 hasRelatedWork W2365649934 @default.
- W3031567761 hasRelatedWork W2380700222 @default.
- W3031567761 hasRelatedWork W2382175112 @default.
- W3031567761 hasRelatedWork W2383465886 @default.
- W3031567761 hasRelatedWork W2386681792 @default.
- W3031567761 hasRelatedWork W2388210534 @default.
- W3031567761 hasRelatedWork W2932433038 @default.
- W3031567761 hasRelatedWork W3029571389 @default.
- W3031567761 hasRelatedWork W3030386104 @default.
- W3031567761 hasRelatedWork W3030448769 @default.
- W3031567761 hasRelatedWork W3031847307 @default.
- W3031567761 hasRelatedWork W3032005215 @default.
- W3031567761 hasRelatedWork W3032759718 @default.
- W3031567761 hasRelatedWork W3032770933 @default.
- W3031567761 hasRelatedWork W3105458846 @default.
- W3031567761 hasVolume "26" @default.
- W3031567761 isParatext "false" @default.
- W3031567761 isRetracted "false" @default.
- W3031567761 magId "3031567761" @default.
- W3031567761 workType "article" @default.